GlassScriptPhysician profile
Ashley Johnson
NPI 1194136267
$3,839.38
in general payments reported to CMS, 2019-2025
30 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $380 · 2021: $758 · 2022: $583 · 2023: $799 · 2024: $605 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,600.93 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $989.23 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $470.72 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $448.57 | 2021-2024 | |
| Pfizer INC. | $289.47 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $272.64 | 2019-2024 | Trintellix |
| Astellas Pharma US INC | $235.42 | 2021-2025 | Veozah |
| Amgen INC. | $163.95 | 2020-2022 | |
| Therapeuticsmd, INC. | $131.17 | 2019-2022 | |
| Exeltis, USA INC. | $127.02 | 2023-2024 | Slynd |
| Daiichi Sankyo INC. | $94.37 | 2019-2022 | |
| Evofem Biosciences, INC. | $72.55 | 2021-2022 | |
| Sage Therapeutics, LLC | $64.66 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $63.14 | 2022-2025 | |
| Organon LLC | $47.43 | 2022-2023 | Jada System, Nexplanon |
| Innovation Technologies INC | $41.04 | 2024 | Irrisept |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $34.71 | 2021 | |
| Axsome Therapeutics, INC. | $33.85 | 2023-2024 | Auvelity |
| Alexion Pharmaceuticals, INC. | $32.03 | 2021-2023 | Ultomiris |
| Vertical Pharmaceuticals, LLC | $31.43 | 2019 | |
| Myovant Sciences INC. | $25.93 | 2022 | |
| Lupin INC. | $24.28 | 2020 | |
| Baxter Healthcare | $22.30 | 2021 | |
| Axonics, INC. | $21.67 | 2024 | Axonics |
| Biohaven Pharmaceuticals, INC. | $18.36 | 2021 | |
| Scynexis, INC. | $16.74 | 2022 | |
| Applied Medical Resources Corporation | $15.39 | 2019 | |
| Davol INC. | $15.39 | 2024 | Progel Applicator Spray Tips |
| Biohaven Pharmaceutical Holding Company LTD. | $12.79 | 2022 | |
| Allergan, INC. | $11.68 | 2020 | |
| Boston Scientific Corporation | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.